---
title: "Maikou Medicine Climbs Over 5% To Record High On Second Listing Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290766164.md"
description: "2335.HK climbed 5% in Hong Kong trading to 38.88 HKD, its highest ever since IPO pricing at 18.2 HKD on listing debut."
datetime: "2026-06-25T02:41:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290766164.md)
  - [en](https://longbridge.com/en/news/290766164.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290766164.md)
---

# Maikou Medicine Climbs Over 5% To Record High On Second Listing Day

Maikou Medicine-B (2335.HK) **climbed** **5%** during regular trading to **38.88 HKD**, hitting an all-time high with turnover exceeding **38.87 million HKD**.

The company officially listed on the Main Board of HKEX on June 24, 2026, becoming the first Northwest innovator pharmaceutical firm under Rule 18A. IPO price was set at **18.2 HKD**; maiden-day close reached **36.9 HKD**, marking a **103%** surge.

Hong Kong retail subscription achieved approximately **1,181 times** oversubscription, while dark pool trading previously spiked over **95%**. The company focuses on peptide drug development; lead product MT1013 is currently in Phase III clinical trials with no commercial revenue yet realized.

### Related Stocks

- [02335.HK](https://longbridge.com/en/quote/02335.HK.md)

## Related News & Research

- [Revisiting stock picks Intel, Progressive, Bristol Myers Squibb](https://longbridge.com/en/news/290775788.md)
- [Globe sustains CDP Supplier Engagement 'A' rating, continuing its collaborative journey across the value chain](https://longbridge.com/en/news/290751646.md)
- [Fortress says Coronation Asset Management raises beneficial stake in Fortress B shares to 20%](https://longbridge.com/en/news/290844550.md)
- [Norges Bank cuts Holmen B stake to 4.81% from 5% threshold](https://longbridge.com/en/news/290830168.md)
- [B Capital leads equity investment in Cadence](https://longbridge.com/en/news/290838536.md)